Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$123,500,531
-$46,331,959 QoQ
Shares Held
788,033
-29.1% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#29
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $598,181,374 across 8 Drug Manufacturers - General names. NVS ranks #3 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,217,376 | $280,143,283 | |
| 2 | NVO |
Novo Nordisk A S
|
3,032,421 | $145,374,262 | |
| 3 | NVS |
Novartis AG
This page
|
788,033 | $123,500,531 | |
| 4 | LLY |
ELI LILLY & Co
|
26,091 | $31,294,330 | |
| 5 | BIIB |
Biogen Inc.
|
77,744 | $16,797,368 | |
| 6 | AMRN |
Amarin Corp Plc\Uk
|
48,369 | $771,001 | |
| 7 | SCLX |
Scilex Holding Co
|
33,064 | $257,899 | |
| 8 | NSRX |
Nasus Pharma Ltd
|
12,200 | $42,700 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,500,531 | 788,033 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $169,832,490 | 1,111,833 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $185,163,959 | 1,343,033 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $240,813,047 | 1,877,831 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $278,099,252 | 2,298,151 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $254,982,741 | 2,287,251 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $259,705,696 | 2,668,849 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $264,623,983 | 2,300,678 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $266,126,791 | 2,499,782 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $284,442,496 | 2,940,582 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $286,561,139 | 2,838,082 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $268,589,031 | 2,636,845 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $237,627,408 | 2,354,845 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $280,364,848 | 3,047,444 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $310,350,398 | 3,420,970 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $241,853,938 | 3,181,870 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $319,808,266 | 3,783,370 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $296,697,667 | 3,381,170 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $326,050,547 | 3,727,570 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $270,465,841 | 3,307,237 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $219,882,834 | 2,409,939 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $202,616,577 | 2,370,339 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $449,329,385 | 4,758,333 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $581,050,023 | 6,681,808 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $724,451,062 | 8,294,608 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $700,116,589 | 8,491,408 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||